Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

ADHD and Anxiety: Clinical Significance and Treatment Implications.

Reimherr FW, Marchant BK, Gift TE, Steans TA.

Curr Psychiatry Rep. 2017 Nov 20;19(12):109. doi: 10.1007/s11920-017-0859-6.

PMID:
29152677
2.

A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.

Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM.

Am J Psychiatry. 2017 Jul 1;174(7):640-648. doi: 10.1176/appi.ajp.2017.16010034. Epub 2017 Mar 31. Erratum in: Am J Psychiatry. 2017 Sep 1;174(9):907.

PMID:
28359201
3.

In memoriam: Paul H. Wender.

Rösler M, Gift T, Marchant B, Reimherr F.

Atten Defic Hyperact Disord. 2016 Dec;8(4):173-174. doi: 10.1007/s12402-016-0209-2. No abstract available.

PMID:
27830480
4.

Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Attrition and Change During Long-term Treatment.

Gift TE, Reimherr FW, Marchant BK, Steans TA, Wender PH.

J Nerv Ment Dis. 2016 May;204(5):355-63. doi: 10.1097/NMD.0000000000000470.

PMID:
27082828
5.

Psychometric properties of the Self-Report Wender-Reimherr Adult Attention Deficit Disorder Scale.

Marchant BK, Reimherr FW, Wender PH, Gift TE.

Ann Clin Psychiatry. 2015 Nov;27(4):267-77; quiz 278-82.

PMID:
26554368
6.

Types of adult attention-deficit hyperactivity disorder (ADHD): baseline characteristics, initial response, and long-term response to treatment with methylphenidate.

Reimherr FW, Marchant BK, Gift TE, Steans TA, Wender PH.

Atten Defic Hyperact Disord. 2015 Jun;7(2):115-28. doi: 10.1007/s12402-015-0176-z. Epub 2015 May 19.

PMID:
25987323
7.

Revising the diagnostic criteria for Attention-Deficit Hyperactivity Disorder (ADHD): an adulthood perspective.

Reimherr FW, Marchant BK, Gift TE, Steans TA, Wender PH.

Atten Defic Hyperact Disord. 2015 Jun;7(2):113-4. doi: 10.1007/s12402-014-0159-5. Epub 2014 Nov 26. No abstract available.

PMID:
25424046
8.

Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.

Marchant BK, Reimherr FW, Robison D, Robison RJ, Wender PH.

Psychol Assess. 2013 Sep;25(3):942-50. doi: 10.1037/a0032797. Epub 2013 May 6.

PMID:
23647041
9.

Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects.

Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, Moreno FA, Dunner DL, Lesem MD, Thompson PM, Husain M, Vine CJ, Banov MD, Bernstein LP, Lehman RB, Brannon GE, Keepers GA, O'Reardon JP, Rudolph RL, Bunker M.

Brain Stimul. 2013 Jul;6(4):631-40. doi: 10.1016/j.brs.2012.09.013. Epub 2012 Oct 23.

PMID:
23122916
10.

The effect of personality disorder symptoms on response to treatment with methylphenidate transdermal system in adults with attention-deficit/hyperactivity disorder.

Olsen JL, Reimherr FW, Marchant BK, Wender PH, Robison RJ.

Prim Care Companion CNS Disord. 2012;14(5). pii: PCC.12m01344. doi: 10.4088/PCC.12m01344. Epub 2012 Oct 11.

11.

Oppositional defiant disorder in adults with ADHD.

Reimherr FW, Marchant BK, Olsen JL, Wender PH, Robison RJ.

J Atten Disord. 2013 Feb;17(2):102-13. doi: 10.1177/1087054711425774. Epub 2011 Nov 18.

PMID:
22100691
12.

A randomized, double-blind, crossover comparison of MK-0929 and placebo in the treatment of adults with ADHD.

Rivkin A, Alexander RC, Knighton J, Hutson PH, Wang XJ, Snavely DB, Rosah T, Watt AP, Reimherr FW, Adler LA.

J Atten Disord. 2012 Nov;16(8):664-74. doi: 10.1177/1087054711423633. Epub 2011 Nov 16.

PMID:
22090395
13.

Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Lyon GJ, Jiang T, Van Wijk R, Wang W, Bodily PM, Xing J, Tian L, Robison RJ, Clement M, Lin Y, Zhang P, Liu Y, Moore B, Glessner JT, Elia J, Reimherr F, van Solinge WW, Yandell M, Hakonarson H, Wang J, Johnson WE, Wei Z, Wang K.

Discov Med. 2011 Jul;12(62):41-55.

14.

Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine.

Marchant BK, Reimherr FW, Halls C, Williams ED, Strong RE, Kondo D, Soni P, Robison RJ.

Atten Defic Hyperact Disord. 2011 Sep;3(3):237-44. doi: 10.1007/s12402-011-0054-2. Epub 2011 Mar 27.

PMID:
21442440
15.

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.

J Clin Psychiatry. 2011 Oct;72(10):1405-12. doi: 10.4088/JCP.09m05355gre.

PMID:
21367355
16.

OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.

Marchant BK, Reimherr FW, Halls C, Williams ED, Strong RE.

Ann Clin Psychiatry. 2010 Aug;22(3):196-204.

PMID:
20680193
17.

A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole.

Reimherr FW, Martin ML, Eudicone JM, Marchant BK, Tran QV, Pikalov A, Marcus RN, Berman RM, Carlson BX.

J Clin Psychopharmacol. 2010 Jun;30(3):300-5. doi: 10.1097/JCP.0b013e3181db320f.

PMID:
20473067
18.

Personality disorders in ADHD Part 3: Personality disorder, social adjustment, and their relation to dimensions of adult ADHD.

Reimherr FW, Marchant BK, Williams ED, Strong RE, Halls C, Soni P.

Ann Clin Psychiatry. 2010 May;22(2):103-12.

PMID:
20445837
19.

Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.

Robison RJ, Reimherr FW, Gale PD, Marchant BK, Williams ED, Soni P, Halls C, Strong RE.

Ann Clin Psychiatry. 2010 May;22(2):94-102.

PMID:
20445836
20.

Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidate.

Williams ED, Reimherr FW, Marchant BK, Strong RE, Halls C, Soni P, Gale PD, Robison RJ.

Ann Clin Psychiatry. 2010 May;22(2):84-93.

PMID:
20445835
21.

Methylphenidate transdermal system in adult ADHD and impact on emotional and oppositional symptoms.

Marchant BK, Reimherr FW, Robison RJ, Olsen JL, Kondo DG.

J Atten Disord. 2011 May;15(4):295-304. doi: 10.1177/1087054710365986. Epub 2010 Apr 21.

PMID:
20410322
22.

A one year trial of methylphenidate in the treatment of ADHD.

Wender PH, Reimherr FW, Marchant BK, Sanford ME, Czajkowski LA, Tomb DA.

J Atten Disord. 2011 Jan;15(1):36-45. doi: 10.1177/1087054709356188. Epub 2010 Jan 13.

PMID:
20071637
23.

Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.

Reimherr F, Amsterdam J, Dunner D, Adler L, Zhang S, Williams D, Marchant B, Michelson D, Nierenberg A, Schatzberg A, Feldman P.

Psychiatry Res. 2010 Jan 30;175(1-2):67-73. doi: 10.1016/j.psychres.2009.01.005. Epub 2009 Dec 6.

PMID:
19969374
24.

Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.

Amsterdam JD, Williams D, Michelson D, Adler LA, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF.

Neuropsychobiology. 2009;59(4):227-33. doi: 10.1159/000226611. Epub 2009 Jul 2.

PMID:
19571597
25.

Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms.

Strong RE, Marchant BK, Reimherr FW, Williams E, Soni P, Mestas R.

Depress Anxiety. 2009;26(3):273-8. doi: 10.1002/da.20538.

PMID:
19016463
26.

Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial.

Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED.

Neuropsychiatr Dis Treat. 2005 Sep;1(3):245-51.

27.

Gender differences in 2 clinical trials of adults with attention-deficit/hyperactivity disorder: a retrospective data analysis.

Robison RJ, Reimherr FW, Marchant BK, Faraone SV, Adler LA, West SA.

J Clin Psychiatry. 2008 Feb;69(2):213-21.

PMID:
18211131
28.

[Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult rating scale].

Rösler M, Retz W, Retz-Junginger P, Stieglitz RD, Kessler H, Reimherr F, Wender PH.

Nervenarzt. 2008 Mar;79(3):320-7. doi: 10.1007/s00115-007-2375-0. German.

PMID:
18210051
29.

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Reimherr F, Miller DD, McGee M, Khan A, Canive JM, Davis SM, Hsiao JK, Lieberman JA; CATIE Investigators.

Schizophr Res. 2008 Mar;100(1-3):39-52. doi: 10.1016/j.schres.2007.11.034. Epub 2008 Jan 11.

PMID:
18191383
30.

The reliability and validity of self- and investigator ratings of ADHD in adults.

Adler LA, Faraone SV, Spencer TJ, Michelson D, Reimherr FW, Glatt SJ, Marchant BK, Biederman J.

J Atten Disord. 2008 May;11(6):711-9. Epub 2007 Nov 19.

PMID:
18025250
31.

Comorbidity and diagnosis of ADHD.

Reimherr FW.

CNS Spectr. 2006 Oct;11(10 Suppl 11):7-9. No abstract available.

PMID:
17712917
32.

Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.

Michelson D, Adler LA, Amsterdam JD, Dunner DL, Nierenberg AA, Reimherr FW, Schatzberg AF, Kelsey DK, Williams DW.

J Clin Psychiatry. 2007 Apr;68(4):582-7.

PMID:
17474814
33.

Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Reimherr F, McGee MF, Keefe RS, McEvoy JP, Hsiao JK, Lieberman JA; CATIE Investigators.

Am J Psychiatry. 2007 Mar;164(3):428-36.

PMID:
17329467
34.
35.

Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.

Cusin C, Fava M, Amsterdam JD, Quitkin FM, Reimherr FW, Beasley CM Jr, Rosenbaum JF, Perlis RH.

J Clin Psychiatry. 2007 Jan;68(1):52-7.

PMID:
17284130
36.

Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.

Adler LA, Sutton VK, Moore RJ, Dietrich AP, Reimherr FW, Sangal RB, Saylor KE, Secnik K, Kelsey DK, Allen AJ.

J Clin Psychopharmacol. 2006 Dec;26(6):648-52.

PMID:
17110824
37.

Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, McGee M, Miller DD, Reimherr F, Khan A, Cañive JM, Lieberman JA.

Psychiatr Serv. 2006 Aug;57(8):1110-6.

PMID:
16870961
38.

Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD.

Adler L, Dietrich A, Reimherr FW, Taylor LV, Sutton VK, Bakken R, Allen AJ, Kelsey D.

Ann Clin Psychiatry. 2006 Apr-Jun;18(2):107-13.

PMID:
16754416
39.

Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.

Spencer TJ, Faraone SV, Michelson D, Adler LA, Reimherr FW, Glatt SJ, Biederman J.

J Clin Psychiatry. 2006 Mar;67(3):415-20.

PMID:
16649828
40.

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA.

J Nerv Ment Dis. 2006 Mar;194(3):164-72.

PMID:
16534433
41.

Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis.

Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Glatt SJ.

Behav Brain Funct. 2005 Oct 3;1:16.

42.

Atomoxetine and stroop task performance in adult attention-deficit/hyperactivity disorder.

Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Seidman L.

J Child Adolesc Psychopharmacol. 2005 Aug;15(4):664-70.

PMID:
16190797
43.

Emotional dysregulation in adult ADHD and response to atomoxetine.

Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, West SA, Soni P.

Biol Psychiatry. 2005 Jul 15;58(2):125-31.

PMID:
16038683
44.

Training raters to assess adult ADHD: reliability of ratings.

Adler LA, Spencer T, Faraone SV, Reimherr FW, Kelsey D, Michelson D, Biederman J.

J Atten Disord. 2005 Feb;8(3):121-6.

PMID:
16009660
45.

Borderline personality disorder in patients with bipolar disorder and response to lamotrigine.

Preston GA, Marchant BK, Reimherr FW, Strong RE, Hedges DW.

J Affect Disord. 2004 Apr;79(1-3):297-303.

PMID:
15023511
46.

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.

Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, Capece JA.

J Clin Psychiatry. 2003 Dec;64(12):1449-54.

PMID:
14728106
47.

Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.

Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, Capece JA, Karvois D.

J Clin Psychiatry. 2003 Nov;64(11):1335-41.

PMID:
14658948
48.

When should a trial of fluoxetine for major depression be declared failed?

Quitkin FM, Petkova E, McGrath PJ, Taylor B, Beasley C, Stewart J, Amsterdam J, Fava M, Rosenbaum J, Reimherr F, Fawcett J, Chen Y, Klein D.

Am J Psychiatry. 2003 Apr;160(4):734-40.

PMID:
12668363
49.

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D.

Biol Psychiatry. 2003 Jan 15;53(2):112-20.

PMID:
12547466
50.

Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau.

Devlin B, Bacanu SA, Roeder K, Reimherr F, Wender P, Galke B, Novasad D, Chu A, TCuenco K, Tiobek S, Otto C, Byerley W.

Mol Psychiatry. 2002;7(7):689-94.

Supplemental Content

Loading ...
Support Center